Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics|April 12, 2013
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma : a NICE single technology appraisalJanette Greenhalgh, Adrian Bagust, Angela Boland, et al.
Pharmacoeconomics - Open|April 16, 2020
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachel Houten, Janette Greenhalgh, James Mahon, et al.
Pharmacoeconomics|October 18, 2018
Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalTosin Lambe, Rui Duarte, James Mahon, et al.
Health Information and Libraries Journal|April 24, 2014
Choosing and using methodological search filters: searchers' viewsSophie Beale, Steven Duffy, Julie Glanville, et al.
Pharmacoeconomics - Open|April 21, 2023
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology AppraisalRachel Houten, Nigel Fleeman, James Mahon, et al.
Health Technology Assessment (Winchester, England)|January 15, 2020
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluationNigel Fleeman, Rachel Houten, Adrian Bagust, et al.
Pharmacoeconomics|March 20, 2017
Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalNigel Fleeman, Adrian Bagust, Angela Boland, et al.
Health Technology Assessment (Winchester, England)|October 15, 2023
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluationRebecca Bresnahan, Rui Duarte, James Mahon, et al.
BMC Pulmonary Medicine|October 5, 2022
A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populationsJames Mahon, Sophie Beale, Hayden Holmes, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 7, 2016
A Randomized Controlled Trial of Extended Brief Intervention for Alcohol-Dependent Patients in an Acute Hospital SettingLynn Owens, Ruwanthi Kolamunnage-Dona, Alan Owens, et al.
Pageof 4